Luye Pharma Group Ltd Capital Reinvestment Ratio
Luye Pharma Group Ltd capital reinvestment ratio. Luye Pharma Group Ltd (LUP) has a Capital Reinvestment Ratio of 1.01x as of June 2021, meaning it reinvests 1% of its operating cash flow (€274.59 Million) in capital expenditures (€278.10 Million). Check Luye Pharma Group Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Luye Pharma Group Ltd (2016–2025)
Capital reinvestment ratio of Luye Pharma Group Ltd from 2016 to 2025. This chart tracks Luye Pharma Group Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore LUP net asset momentum to track the company's year-over-year net asset growth rate.
Luye Pharma Group Ltd Capital Reinvestment Ratio by Year (2016–2025)
Luye Pharma Group Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Luye Pharma Group Ltd.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | €1.78 Billion | €1.00 Billion | ▼ -94.5% |
| 2024 | 10.18x | €167.76 Million | €1.71 Billion | ▲ +1294.4% |
| 2023 | 0.73x | €1.60 Billion | €1.17 Billion | ▲ +3.8% |
| 2022 | 0.70x | €1.65 Billion | €1.16 Billion | ▼ -76.9% |
| 2021 | 3.05x | €182.37 Million | €556.20 Million | ▲ +354.9% |
| 2020 | 0.67x | €1.03 Billion | €692.81 Million | ▼ -4.6% |
| 2019 | 0.70x | €1.42 Billion | €999.34 Million | ▲ +0.9% |
| 2018 | 0.70x | €1.05 Billion | €728.16 Million | ▲ +32.3% |
| 2017 | 0.53x | €964.10 Million | €507.32 Million | ▼ -2.4% |
| 2016 | 0.54x | €592.03 Million | €319.14 Million | — |